Search Results - "NABER, Christoph K"

Staphylococcus aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies by Naber, Christoph K.

“…Staphylococcus aureus is a major cause of bacteremia, and S. aureus bacteremia is associated with higher morbidity and mortality, compared with bacteremia…”
Get full text

Value of plasma fibrin D-dimers for detection of acute aortic dissection by Eggebrecht, Holger, Naber, Christoph K., Bruch, Christian, Kröger, Knut, von Birgelen, Clemens, Schmermund, Axel, Wichert, Marc, Bartel, Thomas, Mann, Klaus, Erbel, Raimund

“…The purpose of this research was to assess the value of systemic inflammatory biomarkers in the detection of acute aortic dissection (AD). Rapid diagnosis and…”
Get full text

Effect of Varying Definitions of Contrast-Induced Acute Kidney Injury and Left Ventricular Ejection Fraction on One-Year Mortality in Patients Having Transcatheter Aortic Valve Implantation by Pyxaras, Stylianos A., MD, Zhang, Yuan, MD, Wolf, Alexander, MD, Schmitz, Thomas, MD, Naber, Christoph K., MD

“…The prognostic relevance of direct contrast toxicity in patients treated with transcatheter aortic valve implantation (TAVI) remains unclear because of the…”
Get full text

Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected by Wijns, William, Naber, Christoph K

Get full text

Successful Repositioning of a Direct Flow Medical 25-mm Valve due to Acute Occlusion of Right Coronary Artery During Transcatheter Aortic Valve Replacement Procedure by Wolf, Alexander, MD, Schmitz, Thomas, MD, Latib, Azeem, MD, Naber, Christoph K., MD

Get full text

Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study) by Giacoppo, Daniele, Alfonso, Fernando, Xu, Bo, Claessen, Bimmer E P M, Adriaenssens, Tom, Jensen, Christoph, Pérez-Vizcayno, María J, Kang, Do-Yoon, Degenhardt, Ralf, Pleva, Leos, Baan, Jan, Cuesta, Javier, Park, Duk-Woo, Schunkert, Heribert, Colleran, Roisin, Kukla, Pavel, Jiménez-Quevedo, Pilar, Unverdorben, Martin, Gao, Runlin, Naber, Christoph K, Park, Seung-Jung, Henriques, José P S, Kastrati, Adnan, Byrne, Robert A

“…Graphical Abstract Graphical Abstract Abstract Aims Consensus is lacking regarding the best treatment for coronary in-stent restenosis (ISR). The two most…”
Get full text

Clinical Consensus Conference: Survey on Gram-Positive Bloodstream Infections with a Focus on Staphylococcus aureus by Naber, Christoph K., Baddour, Larry M., Giamarellos-Bourboulis, Evangelos J., Gould, Ian M., Herrmann, Mathias, Hoen, Bruno, Karchmer, Adolf W., Kobayashi, Yoshio, Kozlov, Roman S., Lew, Daniel, Miró, José M, Moellering, Robert C., Philippe, Moreillon, Peters, Georg, Rubinstein, Ethan, Seifert, Harald, Corey, G. Ralph

“…The increased incidence over the past decade of bloodstream infections (BSIs) caused by gram-positive bacteria, particularly methicillin-resistant…”
Get full text

Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis by Giacoppo, Daniele, Alfonso, Fernando, Xu, Bo, Claessen, Bimmer E P M, Adriaenssens, Tom, Jensen, Christoph, Pérez-Vizcayno, María J, Kang, Do-Yoon, Degenhardt, Ralf, Pleva, Leos, Baan, Jan, Cuesta, Javier, Park, Duk-Woo, Kukla, Pavel, Jiménez-Quevedo, Pilar, Unverdorben, Martin, Gao, Runlin, Naber, Christoph K, Park, Seung-Jung, Henriques, José P S, Kastrati, Adnan, Byrne, Robert A

“…In patients with coronary in-stent restenosis (ISR) requiring reintervention, it is unclear if the choice of treatment should depend on whether the restenotic…”
Get full text

Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead addition by Harper, Mariko W, Uslan, Daniel Z, Greenspon, Arnold J, Baddour, Larry M, Carrillo, Roger G, Danik, Stephan B, Tolosana, Jose M, Le, Katherine, Miro, Jose M, Naber, Christoph K, Peacock, James, Sohail, Muhammad Rizwan, Vikram, Holenarasipur R, Prutkin, Jordan M

“…ObjectiveTo explore differences in clinical manifestations and outcomes in those patients who develop infection after undergoing initial implantation versus…”
Get full text

Impact of Admission Blood Glucose on Outcomes of Nondiabetic Patients With Acute ST-Elevation Myocardial Infarction (from the German Acute Coronary Syndromes [ACOS] Registry) by Naber, Christoph K., MD, PhD, Mehta, Rajendra H., MD, MS, Jünger, Claus, MD, MSan, Zeymer, Uwe, MD, Wienbergen, Harm, MD, Sabin, Georg V., MD, PhD, Erbel, Raimund, MD, PhD, Senges, Jochen, MD, PhD, Gitt, Anselm, MD

“…High blood glucose in patients with acute coronary syndromes have been associated with adverse short-term outcomes in patients without diabetes. However, the…”
Get full text

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study by Naber, Christoph K, Urban, Philip, Ong, Paul J, Valdes-Chavarri, Mariano, Abizaid, Alexandre A, Pocock, Stuart J, Fabbiocchi, Franco, Dubois, Christophe, Copt, Samuel, Greene, Samantha, Morice, Marie-Claude

“…Although a true clinical challenge, high bleeding risk patients with an acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) have…”
Get full text

Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective by Tamburino, Corrado, Latib, Azeem, van Geuns, Robert-Jan, Sabate, Manel, Mehilli, Julinda, Gori, Tommaso, Achenbach, Stephan, Alvarez, Manuel Pan, Nef, Holger, Lesiak, Maciej, Di Mario, Carlo, Colombo, Antonio, Naber, Christoph K., Caramanno, Giuseppe, Capranzano, Piera, Brugaletta, Salvatore, Geraci, Salvatore, Araszkiewicz, Aleksander, Mattesini, Alessio, Pyxaras, Stylianos A., Rzeszutko, Lukasz, Depukat, Rafalo, Diletti, Roberto, Boone, Els, Capodanno, Davide, Dudek, Dariusz

Get full text

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial by Lansky, Alexandra, Wijns, William, Xu, Bo, Kelbæk, Henning, van Royen, Niels, Zheng, Ming, Morel, Marie-angèle, Knaapen, Paul, Slagboom, Ton, Johnson, Thomas W, Vlachojannis, Georgios, Arkenbout, Karin E, Holmvang, Lene, Janssens, Luc, Ochala, Andrzej, Brugaletta, Salvatore, Naber, Christoph K, Anderson, Richard, Rittger, Harald, Berti, Sergio, Barbato, Emanuele, Toth, Gabor G, Maillard, Luc, Valina, Christian, Buszman, Paweł, Thiele, Holger, Schächinger, Volker, Baumbach, Andreas

“…The FIREHAWK is a drug-eluting stent with a fully biodegradable sirolimus-containing polymer coating localised to recessed abluminal grooves on the stent…”
Get full text

ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease by ROSENHEK, Raphael, LUNG, Bernard, ACARTÜRK, Esmeray, GOHLKE-BÄRWOLF, Christa, TORNOS, Pilar, ANTUNES, Manuel J, PRENDERGAST, Bernard D, OTTO, Catherine M, PIETER KAPPETEIN, Arie, STEPINSKA, Janina, KADEN, Jens J, NABER, Christoph K

“…Risk scores provide an important contribution to clinical decision-making, but their validity has been questioned in patients with valvular heart disease…”
Get full text

First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation by NABER, Christoph K, GHANEM, Alexander, ABIZAID, Alexander A, WOLF, Alexander, SINNING, Jan-Malte, WERNER, Nikos, NICKENIG, Georg, SCHMITZ, Thomas, GRUBE, Eberhard

“…We describe the first-in-human experience with a novel cerebral embolic protection device used during transcatheter aortic valve implantation (TAVI). One…”
Get full text

Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial by Jensen, Christoph J., Richardt, Gert, Tölg, Ralph, Erglis, Andrejs, Skurk, Carsten, Jung, Werner, Neumann, Franz Josef, Stangl, Karl, Brachmann, Johannes, Fischer, Dieter, Mehilli, Julinda, Rieber, Johannes, Wiemer, Marcus, Schofer, Joachim, Sack, Stefan, Naber, Christoph K.

Get full text

Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality by Zhang, Yuan, Pyxaras, Stylianos A., Wolf, Alexander, Schmitz, Thomas, Naber, Christoph K.

“…Aims To compare 30‐day performance of three different type of transcatheter aortic valve implantation (TAVI) prosthesis: Direct Flow Medical (DFM), Medtronic…”
Get full text

Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN‐TAVI registry by Panoulas, Vasileios F., Chandrasekhar, Jaya, Busi, Gherardo, Ruparelia, Neil, Zhang, Zhongjie, Mehilli, Julinda, Sartori, Samantha, Lefèvre, Thierre, Presbitero, Patrizia, Capranzano, Piera, Tchetche, Didier, Iadanza, Alessandro, Sardella, Gennaro, Van Mieghem, Nicolas M., Meliga, Emanuele, Dumonteil, Nicolas, Fraccaro, Chiara, Trabattoni, Daniela, Sharma, Samin, Ferrer‐Gracia, Maria‐Cruz, Naber, Christoph K., Kievit, Peter C., Snyder, Clayton, Sutaria, Nilesh, Sen, Sayan, Malik, Iqbal S., Morice, Marie‐Claude, Nihoyannopoulos, Petros, Petronio, Anna Sonia, Mehran, Roxana, Chieffo, Alaide, Mikhail, Ghada W.

“…Objective To evaluate the incidence, predictors and outcomes of female patients with patient‐prosthesis mismatch (PPM) following transcatheter aortic valve…”
Get full text

Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry) by Pagnesi, Matteo, Kim, Won-Keun, Conradi, Lenard, Barbanti, Marco, Stefanini, Giulio G., Schofer, Joachim, Hildick-Smith, David, Pilgrim, Thomas, Abizaid, Alexandre, Zweiker, David, Testa, Luca, Taramasso, Maurizio, Wolf, Alexander, Webb, John G., Sedaghat, Alexander, Van der Heyden, Jan A.S., Ziviello, Francesca, MacCarthy, Philip, Hamm, Christian W., Bhadra, Oliver D., Schäfer, Ulrich, Costa, Giuliano, Tamburino, Corrado, Cannata, Francesco, Reimers, Bernhard, Eitan, Amnon, Alsanjari, Osama, Asami, Masahiko, Windecker, Stephan, Siqueira, Dimytri, Schmidt, Albrecht, Bianchi, Giovanni, Bedogni, Francesco, Saccocci, Matteo, Maisano, Francesco, Jensen, Christoph J., Naber, Christoph K., Alenezi, Abdullah, Wood, David A., Sinning, Jan-Malte, Brouwer, Jorn, Tzalamouras, Vasileios, Van Mieghem, Nicolas M., Colombo, Antonio, Latib, Azeem

“…Safety and feasibility of transfemoral Acurate neo implantation without systematic predilatation are not fully investigated. Our aim was to evaluate the use…”
Get full text

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trial by Lansky, Alexandra J, Xu, Bo, Baumbach, Andreas, Kelbæk, Henning, van Royen, Niels, Zheng, Ming, Knaapen, Paul, Slagboom, Ton, Johnson, Thomas W, Vlachojannis, Georgios J, Arkenbout, Karin E, Holmvang, Lene, Janssens, Luc, Brugaletta, Salvatore, Naber, Christoph K, Schmitz, Thomas, Anderson, Richard, Rittger, Harald, Berti, Sergio, Barbato, Emanuele, Toth, Gabor G, Maillard, Luc, Valina, Christian M, Buszman, Paweł E, Thiele, Holger, Schächinger, Volker, Wijns, William

“…In the prospective, multicentre, randomised TARGET All Comers study, percutaneous coronary intervention (PCI) with the FIREHAWK biodegradable-polymer…”
Get more information